about
Asthma inhaler adherence determinants in adults: systematic review of observational data.Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience.Appropriateness of colonoscopy requests according to EPAGE-II in the Spanish region of Catalonia.Impact of IPDE-SQ personality disorders on the healthcare and societal costs of fibromyalgia patients: a cross-sectional study.Efficacy of low-frequency low-intensity electrotherapy in the treatment of breast cancer-related lymphoedema: a cross-over randomized trial.Chronic kidney disease in hypertensive subjects ≥60 years treated in Primary Care.Effectiveness of Brief Systemic Therapy versus Cognitive Behavioral Therapy in routine clinical practice.Estimating preferences for treatments in patients with localized prostate cancer.Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.Discriminative capacity of the EQ-5D, SF-6D, and SF-12 as measures of health status in population health survey.Association between EBRT dose volume histograms and quality of life in prostate cancer patientsNormas de referencia para el Cuestionario de Salud SF-12 versión 2 basadas en población general de Cataluña[Chronic kidney disease in Primary Health Care: prevalence and associated risk factors]Effectiveness of the Epley manoeuvre in posterior canal benign paroxysmal positional vertigo: a randomised clinical trial in primary careAssociation between affective disorders presenting before and during pregnancy and pre-term birth, considering socio-demographic factors, obstetric factors, health conditions, and use of medication
P50
Q30878070-51501EC5-0823-4AE4-853D-596507F22A5CQ33845930-D4DA1143-1BD3-4594-906C-6871C93B532CQ35820049-664406C8-B469-47EB-91D8-84B569333313Q36035193-1AE02A06-DFC0-41D1-9650-B46E0631898AQ36613426-5636A3C2-4577-463D-B26B-4894828F0586Q38656960-C828F299-E5CB-4139-8975-1A1F53EE11CBQ39570155-13CF0CF6-8F59-4D4A-8BB0-A43517FB2C34Q41710287-0AE9B32E-2661-46BD-B616-AAC94C84C3FFQ48207972-56564770-1A76-4A69-88E7-122AE5F9851EQ48849298-51142258-5002-4488-87BA-7068A55E9174Q57166124-64600476-B79D-4791-BFF5-6F9C3DD1F49DQ58445267-E9CC7CF9-3C22-443C-9440-66B2C793035AQ85295451-0BA68F49-C385-40B6-BCBB-8110B78DFDCCQ90227038-ADECFE46-5BAF-4B4E-8829-519673903A7AQ93219503-D9706DB5-D76A-4CD0-BC12-734C4CB446C5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Oriol Cunillera
@ast
Oriol Cunillera
@en
Oriol Cunillera
@es
Oriol Cunillera
@nl
type
label
Oriol Cunillera
@ast
Oriol Cunillera
@en
Oriol Cunillera
@es
Oriol Cunillera
@nl
prefLabel
Oriol Cunillera
@ast
Oriol Cunillera
@en
Oriol Cunillera
@es
Oriol Cunillera
@nl
P106
P1153
35762806900
P31
P496
0000-0003-2891-099X